It could be a game-changer for the millions of Americans who suffer from sleep apnea. A new first-of-its-kind pill could ...

Sleep apnea affects as many as 80 million in the U.S. Now Apnimed, the $400 million company behind the first ever pill to ...

A nightly oral pill for obstructive sleep apnea is close to regulatory approval in the US. This medicine-based option could ...

If you have obstructive sleep apnea (OSA)—a condition that causes a partial or complete collapse of your upper airway while sleeping—you’re likely familiar with continuous positive airway pressure ...

Sleep apnea is a debilitating disease that many sufferers don’t even realize they have. Those afflicted with the condition ...

Around 22 million Americans have sleep apnea. Traditional continuous positive airway pressure, or CPAP, machines are the standard treatment. However, they can be loud, uncomfortable and have a pesky ...

More than 12 million Americans suffer with sleep apnea, a potentially serious sleep disorder that causes your breathing to start and stop during rest and can lead to heart disease, stroke and diabetes ...

Learn the hidden signs of sleep apnea, its impact on health, and how effective treatment can restore your energy and improve ...

Sleep apnea is a common sleep disorder that affects millions of people worldwide. It is characterized by episodes of interrupted breathing during sleep, which can lead to loud snoring, disrupted sleep ...

Biotech firm Apnimed plans to seek FDA approval for its sleep apnea drug, with market availability expected by 2027 ...

ORLANDO -- Tirzepatide (Zepbound) improved symptoms of moderate-to-severe obstructive sleep apnea (OSA) in people with obesity, regardless of positive airway pressure (PAP) use, the phase III SURMOUNT ...

Zepbound, a popular weight loss drug, also seems to help people with obstructive sleep apnea, drugmaker Eli Lilly said Wednesday. Based on results from trials in people with sleep apnea, the company ...